News | November 08, 2021
Divis Labs PAT at Rs 606.46 cr. in Q2FY22
Divi's Laboratories Limited has reported consolidated financial results for the period ended September 30, 2021.
Divi's Laboratories Limited has reported consolidated financial results for the period ended September 30, 2021.
It is the world’s first DNA-based Covid vaccine
The drug helps in managing cholesterol
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
Applications remain under review by others including U.S. Food and Drug Administration and the European Medicines Agency
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO
Biocon Biologics and Viatris co-developed the products
The solution helps the pharma enterprises drive efficiencies, save costs, and increase productivity
Sun Pharma has reported consolidated financial results for the period ended September 30, 2021.
The preregistrations are aimed at registering both healthy children and those with comorbidities whereas preference will be given for children with comorbidities
Subscribe To Our Newsletter & Stay Updated
